Global export footprint Meiji Pharma Spain exports medicines to global markets from its Alcalá de Henares facilities, presenting opportunities to target distributors, contract manufacturers, and hospitals in Europe, Americas, and Asia.

Manufacturing and R&D strong With two production plants and an integrated R&D center, plus capabilities to manufacture cefalosporin third generation and hyaluronic acid products, there are possibilities for collaboration in API supply, contract manufacturing, and formulation development.

Award-winning partner Recognition as Outstanding Performance Award recipient positions Meiji Pharma Spain as a reputable, reliable supplier, which can be leveraged in outreach to buyers seeking proven performance and stable supply chains.

Regulatory and quality focus The site’s alignment with national and international regulatory demands suggests suitability for long-term supply agreements, audits, and GMP-compliant manufacturing services for global customers.

Mid-market scale with high potential With 201-500 employees and revenue in the lower hundreds of millions range, Meiji Pharma Spain sits between midsize contract manufacturing options and larger players, offering a balance of agility, customization, and scalable capacity for new product introductions.